I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

Gross Margin
InDex Pharmaceuticals Holding AB

-126 944%
Current
-23 401%
Average
48.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-126 944%
=
Gross Profit
-126.9m
/
Revenue
100k

Gross Margin Across Competitors

Country SE
Market Cap 3.5B SEK
Gross Margin
-126 944%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 788.1B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.4T DKK
Gross Margin
85%
Country US
Market Cap 384.8B USD
Gross Margin
69%
Country US
Market Cap 259.4B USD
Gross Margin
76%
Country CH
Market Cap 213.6B CHF
Gross Margin
73%
Country UK
Market Cap 171.2B GBP
Gross Margin
82%
Country CH
Market Cap 183.5B CHF
Gross Margin
75%
Country US
Market Cap 160.4B USD
Gross Margin
71%

Profitability Report

View the profitability report to see the full profitability analysis for InDex Pharmaceuticals Holding AB.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-126 944%
=
Gross Profit
-126.9m
/
Revenue
100k
What is the Gross Margin of InDex Pharmaceuticals Holding AB?

Based on InDex Pharmaceuticals Holding AB's most recent financial statements, the company has Gross Margin of -126 944%.